相似文献
1
Priorities for Cardiovascular Outcomes Research: A Report of the National Heart, Lung, and Blood Institute's Centers for Cardiovascular Outcomes Research Working Group.心血管结局研究的优先事项：美国国立心肺血液研究所心血管结局研究中心工作组报告
Circ Cardiovasc Qual Outcomes. 2017 Jul;10(7). doi: 10.1161/CIRCOUTCOMES.115.001967.
2
Centers for cardiovascular outcomes research: defining a collaborative vision.心血管结局研究中心：定义一个合作愿景。
Circ Cardiovasc Qual Outcomes. 2013 Mar 1;6(2):223-8. doi: 10.1161/CIRCOUTCOMES.0b013e31828e8d5c. Epub 2013 Mar 12.
3
Implementing the National Heart, Lung, and Blood Institute's Strategic Vision in the Division of Cardiovascular Sciences.在心血管科学分部实施国家心肺血液研究所的战略愿景。
Circ Res. 2019 Feb 15;124(4):491-497. doi: 10.1161/CIRCRESAHA.118.314338.
4
National Heart, Lung, and Blood Institute and the translation of cardiovascular discoveries into therapeutic approaches.国家心肺血液研究所和将心血管发现转化为治疗方法。
Circ Res. 2013 Apr 26;112(9):1212-8. doi: 10.1161/CIRCRESAHA.113.301100.
5
Priorities for Patient-Centered Research in Valvular Heart Disease: A Report From the National Heart, Lung, and Blood Institute Working Group.以患者为中心的瓣膜性心脏病研究重点：美国国立心肺血液研究所工作组的报告。
J Am Heart Assoc. 2020 May 5;9(9):e015975. doi: 10.1161/JAHA.119.015975. Epub 2020 Apr 24.
6
Report of the National Heart, Lung, and Blood Institute working group on outcomes research in cardiovascular disease.美国国立心肺血液研究所心血管疾病预后研究工作组报告
Circulation. 2005 Jun 14;111(23):3158-66. doi: 10.1161/CIRCULATIONAHA.105.536102.
7
Stakeholder Engagement in Late-Stage Translation Research and Implementation Science: Perspectives From the National Heart, Lung, and Blood Institute.利益相关者参与晚期翻译研究和实施科学：来自国家心肺血液研究所的观点。
Glob Heart. 2019 Jun;14(2):191-194. doi: 10.1016/j.gheart.2019.06.005.
8
Concept of a national primary care patient-centered outcomes research laboratory.国家以初级保健患者为中心的疗效研究实验室的概念。
Ann Fam Med. 2013 May-Jun;11(3):282-3. doi: 10.1370/afm.1538.
9
Rare Lung Disease Research: National Heart, Lung, and Blood Institute's Commitment to Partnership and Progress.罕见肺病研究：美国国立心肺血液研究所对合作与进步的承诺。
Chest. 2019 Sep;156(3):438-444. doi: 10.1016/j.chest.2019.05.004. Epub 2019 May 20.
10
The prevention and management of chronic disease in primary care: recommendations from a knowledge translation meeting.基层医疗中慢性病的预防与管理：知识转化会议的建议
BMC Res Notes. 2015 Oct 15;8:571. doi: 10.1186/s13104-015-1514-0.
引用本文的文献
1
Introduction to Mammalian Genome special issue: cardiovascular disease in the Mammalian Genome.《哺乳动物基因组》特刊：哺乳动物基因组中的心血管疾病
Mamm Genome. 2023 Jun;34(2):105-106. doi: 10.1007/s00335-023-09998-9.
2
Predictors of health-related quality of life after cardiac surgery: a systematic review.心脏手术后健康相关生活质量的预测因素：系统评价。
Health Qual Life Outcomes. 2022 May 18;20(1):79. doi: 10.1186/s12955-022-01980-4.
3
Conceptual Framework for Personal Recovery in Patients With Acute Myocardial Infarction.急性心肌梗死患者个人康复的概念框架。
J Am Heart Assoc. 2021 Oct 5;10(19):e022354. doi: 10.1161/JAHA.121.022354. Epub 2021 Sep 28.
4
Inflection Point: Ideas for Accelerating Breakthroughs and Improving Cardiovascular Health.转折点：加速突破与改善心血管健康的理念
Circ Cardiovasc Qual Outcomes. 2020 Dec;13(12):e007615. doi: 10.1161/CIRCOUTCOMES.120.007615. Epub 2020 Nov 17.
5
Race-based and sex-based differences in bioactive lipid mediators after myocardial infarction.心肌梗死后生物活性脂质介质的种族和性别差异。
ESC Heart Fail. 2020 Aug;7(4):1700-1710. doi: 10.1002/ehf2.12730. Epub 2020 May 4.
6
Clinical value of non-coding RNAs in cardiovascular, pulmonary, and muscle diseases.非编码 RNA 在心血管、肺部和肌肉疾病中的临床价值。
Am J Physiol Cell Physiol. 2020 Jan 1;318(1):C1-C28. doi: 10.1152/ajpcell.00078.2019. Epub 2019 Sep 4.
本文引用的文献
1
Risk for Hospitalized Heart Failure Among New Users of Saxagliptin, Sitagliptin, and Other Antihyperglycemic Drugs: A Retrospective Cohort Study.沙格列汀、西他列汀及其他降糖药物新使用者住院心力衰竭风险：一项回顾性队列研究
Ann Intern Med. 2016 Jun 7;164(11):705-14. doi: 10.7326/M15-2568. Epub 2016 Apr 26.
2
Merging Electronic Health Record Data and Genomics for Cardiovascular Research: A Science Advisory From the American Heart Association.整合电子健康记录数据与基因组学用于心血管研究：美国心脏协会的科学咨询意见
Circ Cardiovasc Genet. 2016 Apr;9(2):193-202. doi: 10.1161/HCG.0000000000000029. Epub 2016 Mar 14.
3
Acquisition, Analysis, and Sharing of Data in 2015 and Beyond: A Survey of the Landscape: A Conference Report From the American Heart Association Data Summit 2015.2015年及以后的数据获取、分析与共享：现状调查：美国心脏协会2015年数据峰会会议报告
J Am Heart Assoc. 2015 Nov 5;4(11):e002810. doi: 10.1161/JAHA.115.002810.
4
A New Global Heart Series.一个全新的全球心脏系列。
Glob Heart. 2013 Sep;8(3):283-284. doi: 10.1016/j.gheart.2013.08.014.
5
Introducing Choosing Wisely®: Next steps in improving healthcare value.介绍“明智选择”®：提升医疗保健价值的后续步骤。
J Hosp Med. 2015 Mar;10(3):187-9. doi: 10.1002/jhm.2305. Epub 2014 Dec 30.
6
'Choosing Wisely': a growing international campaign.“明智选择”：一项日益发展的国际运动。
BMJ Qual Saf. 2015 Feb;24(2):167-74. doi: 10.1136/bmjqs-2014-003821. Epub 2014 Dec 31.
7
Accountable care organizations--the risk of failure and the risks of success.accountable care organizations——失败的风险与成功的风险。
N Engl J Med. 2014 Oct 30;371(18):1750-1. doi: 10.1056/NEJMe1410660.
8
Changes in health care spending and quality 4 years into global payment.全球支付实施 4 年后医疗支出和质量的变化
N Engl J Med. 2014 Oct 30;371(18):1704-14. doi: 10.1056/NEJMsa1404026.
9
Unique device identifiers for coronary stent postmarket surveillance and research: a report from the Food and Drug Administration Medical Device Epidemiology Network Unique Device Identifier demonstration.冠状动脉支架上市后监测与研究的唯一设备标识符：来自美国食品药品监督管理局医疗器械流行病学网络唯一设备标识符示范项目的报告
Am Heart J. 2014 Oct;168(4):405-413.e2. doi: 10.1016/j.ahj.2014.07.001. Epub 2014 Jul 7.
10
Hospital cardiovascular outcome measures in federal pay-for-reporting and pay-for-performance programs: a brief overview of current efforts.联邦按报告付费和按绩效付费计划中的医院心血管结局指标：当前工作简要概述
Circ Cardiovasc Qual Outcomes. 2014 Sep;7(5):627-33. doi: 10.1161/CIRCOUTCOMES.114.001364. Epub 2014 Sep 9.
Zotero 插件